| |
| |
|
| Insider
Information: |
Aguiar Eric |
| Relationship: |
Director, 10% Owner |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
10,325,061 |
|
|
Indirect Shares
|
26,326,894 |
|
|
| Direct
Value |
$23,937,546 |
|
|
|
Indirect Value
|
$3,003,371,977 |
|
|
| Total
Shares |
36,651,955 |
|
|
| Total
Value |
$3,027,309,523 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 16.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Middlebrook Pharmaceuticals Corp |
MBRKQ |
10% Owner |
2007-04-12 |
6,215,389 |
2003-10-22 |
0 |
Premium* |
|
|
Altimmune, Inc |
ALT |
10% Owner |
2007-08-03 |
3,297,174 |
2007-08-03 |
0 |
Premium* |
|
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2013-07-15 |
687,176 |
2013-07-15 |
1,751,393 |
Premium* |
|
|
Invitae Corp |
NVTA |
Director |
2023-04-27 |
125,322 |
2016-11-18 |
0 |
Premium* |
|
|
Eidos Therapeutics, Inc. |
EIDX |
Director, 10% Owner |
2019-05-24 |
0 |
2019-07-03 |
24,575,501 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVTA |
Invitae Corp |
Director |
– • – |
2023-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
70,422 |
125,322 |
0 |
- |
|
| NVTA |
Invitae Corp |
Director |
– • – |
2022-04-28 |
4 |
A |
$0.00 |
$0 |
D/D |
43,400 |
54,900 |
0 |
- |
|
| NVTA |
Invitae Corp |
Director |
– • – |
2021-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
11,500 |
11,500 |
0 |
- |
|
| NVTA |
Invitae Corp |
Director |
– • – |
2020-12-16 |
4 |
AS |
$50.74 |
$510,003 |
D/D |
(10,000) |
0 |
0 |
% |
|
| NVTA |
Invitae Corp |
Director |
– • – |
2020-12-16 |
4 |
OE |
$24.16 |
$241,600 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| NVTA |
Invitae Corp |
Director |
– • – |
2020-11-16 |
4 |
OE |
$8.51 |
$288,200 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| NVTA |
Invitae Corp |
Director |
– • – |
2020-11-16 |
4 |
AS |
$46.36 |
$1,395,711 |
D/D |
(30,000) |
0 |
0 |
% |
|
| NVTA |
Invitae Corp |
Director |
– • – |
2020-07-15 |
4 |
AS |
$33.44 |
$339,853 |
D/D |
(10,000) |
0 |
0 |
% |
|
| NVTA |
Invitae Corp |
Director |
– • – |
2020-07-15 |
4 |
OE |
$8.08 |
$80,800 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
Director |
– • • |
2019-07-03 |
4 |
B |
$29.90 |
$26,382,796 |
I/I |
882,353 |
24,575,501 |
2.25 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
Director |
– • • |
2019-05-24 |
4 |
B |
$25.93 |
$28,622,779 |
I/I |
1,103,848 |
23,693,148 |
2.25 |
- |
|
| NVTA |
Invitae Corp |
Director |
– • – |
2018-11-27 |
4 |
S |
$13.50 |
$135,000 |
D/D |
(10,000) |
0 |
0 |
- |
|
| NVTA |
Invitae Corp |
Director |
– • – |
2016-11-18 |
4 |
B |
$6.28 |
$62,834 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
10% Owner |
– – • |
2013-07-15 |
4/A |
A |
$6.00 |
$10,054,062 |
D/D |
1,675,677 |
1,675,677 |
0 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
10% Owner |
– – • |
2013-07-15 |
4/A |
A |
$6.00 |
$4,577,352 |
I/I |
762,892 |
762,892 |
0 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
10% Owner |
– – • |
2013-07-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
687,176 |
|
- |
|
| OCRX |
Ocera Therapeutics Inc |
10% Owner |
– – • |
2013-07-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,751,393 |
|
- |
|
| ALT |
Altimmune, Inc |
10% Owner |
– – • |
2007-08-03 |
4 |
B |
$7.66 |
$957,500 |
D/D |
125,000 |
250,000 |
2.45 |
- |
|
| ALT |
Altimmune, Inc |
10% Owner |
– – • |
2007-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,047,174 |
3,297,174 |
0 |
- |
|
| ALT |
Altimmune, Inc |
|
– – – |
2007-08-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
125,000 |
|
- |
|
| MBRKQ |
Middlebrook Pharmaceutica... |
10% Owner |
– – • |
2007-04-12 |
4 |
B |
$2.36 |
$1,614,178 |
D/D |
682,903 |
6,215,389 |
2.45 |
- |
|
| MBRKQ |
Middlebrook Pharmaceutica... |
10% Owner |
– – • |
2003-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
5,532,486 |
5,532,486 |
|
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
